https://www.medxy.ai/news/vi/sputum-leukocytes-copd-asthma 2026-10-06T07:38:02.000Z daily 0.75 https://www.medxy.ai/news/ja/81673-2 2026-10-06T07:38:18.000Z daily 0.75 https://www.medxy.ai/news/zh/sputum-cell-composition 2026-10-06T07:40:20.000Z daily 0.75 https://www.medxy.ai/news/enhanced-diagnostic-accuracy-and-safety-of-ceus-guided-biopsy-for-subpleural-lung-lesions-insights-from-a-large-multicenter-rct 2026-10-06T07:42:37.000Z daily 0.75 https://www.medxy.ai/news/vi/81677-2 2026-10-06T07:42:51.000Z daily 0.75 https://www.medxy.ai/news/ja/81678-2 2026-10-06T07:43:22.000Z daily 0.75 https://www.medxy.ai/news/zh/ceus-biopsy-accuracy 2026-10-06T07:43:37.000Z daily 0.75 https://www.medxy.ai/news/tisa-818-in-ards-due-to-pulmonary-infection-promising-safety-and-early-efficacy-signals-with-the-2023-global-definition 2026-10-06T07:46:37.000Z daily 0.75 https://www.medxy.ai/news/vi/tisa-ards-safety 2026-10-06T07:46:50.000Z daily 0.75 https://www.medxy.ai/news/ja/81683-2 2026-10-06T07:47:12.000Z daily 0.75 https://www.medxy.ai/news/zh/tisa-818-ards-study 2026-10-06T07:47:30.000Z daily 0.75 https://www.medxy.ai/news/vi/lisocabtagene-maraleucel-followup 2026-10-06T07:48:53.000Z daily 0.75 https://www.medxy.ai/news/ja/relapsed-follicular-lymphoma 2026-10-05T12:53:14.000Z daily 0.75 https://www.medxy.ai/news/zh/lisocabtagene-followup 2026-10-06T07:48:31.000Z daily 0.75 https://www.medxy.ai/news/decoding-ctcl-a-single-cell-atlas-reveals-oncogenic-pathways-and-immune-resistance-mechanisms 2026-10-05T22:21:08.000Z daily 0.75 https://www.medxy.ai/news/vi/ctcl-single-cell-map 2026-10-06T07:51:28.000Z daily 0.75 https://www.medxy.ai/news/ja/81693-2 2026-10-06T07:51:49.000Z daily 0.75 https://www.medxy.ai/news/zh/ctcl-cancer-pathways 2026-10-06T07:52:06.000Z daily 0.75 https://www.medxy.ai/news/long-term-efficacy-and-safety-of-first-line-ibrutinib-venetoclax-in-older-patients-with-chronic-lymphocytic-leukemia-insights-from-the-67-month-glow-study 2026-10-05T22:24:39.000Z daily 0.75 https://www.medxy.ai/news/vi/ibrutinib-venetoclax-results 2026-10-06T07:53:16.000Z daily 0.75 https://www.medxy.ai/news/ja/ibrutinib-venetoclax-long-term 2026-10-06T07:53:32.000Z daily 0.75 https://www.medxy.ai/news/zh/ibrutinib-venetoclax-longterm-results 2026-10-06T07:53:53.000Z daily 0.75 https://www.medxy.ai/news/targeting-ror1-in-chronic-lymphocytic-leukemia-insights-from-the-zilovertamab-and-ibrutinib-combination-in-high-risk-del17p-disease 2026-10-06T07:55:29.000Z daily 0.75 https://www.medxy.ai/news/vi/81702-2 2026-10-06T07:55:54.000Z daily 0.75 https://www.medxy.ai/news/ja/81703-2 2026-10-06T07:56:11.000Z daily 0.75 https://www.medxy.ai/news/zh/ror1-chronic-lymphocytic-leukemia 2026-10-06T07:56:25.000Z daily 0.75 https://www.medxy.ai/news/targeting-leukemic-stem-cells-in-aml-overcoming-pi3k-inhibitor-resistance-through-epigenetic-modulation 2026-10-06T07:57:30.000Z daily 0.75 https://www.medxy.ai/news/vi/aml-leukemia-treatment 2026-10-06T07:57:44.000Z daily 0.75 https://www.medxy.ai/news/ja/aml-leukemia-targeting 2026-10-06T07:58:05.000Z daily 0.75 https://www.medxy.ai/news/zh/target-aml-stemcells 2026-10-06T07:58:23.000Z daily 0.75 https://www.medxy.ai/news/influence-of-clonal-hematopoiesis-and-neutropenia-on-car-t-therapy-outcomes-in-hematologic-malignancies 2026-10-06T08:00:14.000Z daily 0.75 https://www.medxy.ai/news/cd25-based-graft-versus-host-disease-prophylaxis-after-haploidentical-hematopoietic-stem-cell-transplantation-comparative-analysis-of-two-prophylactic-regimens 2026-10-06T08:03:24.000Z daily 0.75 https://www.medxy.ai/news/vi/cd25-gvhd-prophylaxis 2026-10-06T08:02:17.000Z daily 0.75 https://www.medxy.ai/news/ja/cd25-gvhd-prevention-2 2026-10-06T08:02:45.000Z daily 0.75 https://www.medxy.ai/news/zh/cd25-gvhd-prevention 2026-10-06T08:03:01.000Z daily 0.75 https://www.medxy.ai/news/targeting-leukemia-stem-cells-in-unfit-acute-myeloid-leukemia-with-a-cd70-directed-third-agent-promise-and-caveats-from-the-elevate-trial 2026-10-06T08:06:34.000Z daily 0.75 https://www.medxy.ai/news/vi/leukemia-stem-cell-targeting 2026-10-06T08:06:51.000Z daily 0.75 https://www.medxy.ai/news/ja/cd70-aml-treatment 2026-10-06T08:07:13.000Z daily 0.75 https://www.medxy.ai/news/zh/cd70-acute-leukemia-stem-cells 2026-10-06T08:07:26.000Z daily 0.75 https://www.medxy.ai/news/optimizing-rabbit-atg-exposure-in-t-replete-hematopoietic-cell-transplantation-insights-from-bmt-ctn-1202 2026-10-06T08:37:13.000Z daily 0.75